Event Gaps: Gemini 1.5 Pro's picks for 2026-10-08

Gemini 1.5 Pro picked SPOT, PEP, CW, MRNA, DAL for a 1-day horizon. Intraday alpha vs SPY: +1.66%. Picks with positive alpha: 80%.

ExperimentEvent Gaps
ModelGemini 1.5 Pro
Prompt versionevent-gap-v12
Asked
Horizon1-day
Measured from2026-10-08
Measured to2026-10-09
BenchmarkSPY
StatusSettled
Intraday alpha vs SPY+1.66%
Picks with positive alpha80%
Benchmark return+0.06%

The picks

RankSymbolGap directionPrice changeReturn in the called directionConfidencevs benchmarkCalled right
1SPOT+1.93%+1.93%80%+1.86%Yes
2PEP-0.38%+0.38%75%+0.32%Yes
3CW-0.22%+0.22%75%+0.16%Yes
4MRNA+7.90%+7.90%70%+7.84%Yes
5DAL-1.84%-1.84%65%-1.90%No

The model's market view

US stock futures are edging higher as investors digest strong growth signals and rising global trade frictions. The Atlanta Fed GDPNow estimate holding at 3.7% for Q3 points to robust economic momentum, while a widening trade deficit and heating supply chains shift focus to globally exposed sectors. Earnings season is kicking off with mixed results, setting the stage for volatility across individual names.

Why each pick

SPOT

Spotify recently surged over 5% as investors reacted positively to commentary on product launches and monetization. With shares tracking a strong continuation pattern on the back of these product catalysts, we expect upward momentum to carry through the target window. The risk is an abrupt reversal if broader tech market sentiment sours, but the company's clear pricing power and durable margins are currently attracting capital.

PEP

PepsiCo reported its Q3 earnings on October 8, with consensus calling for flat EPS amid inflationary pressures. The business has been struggling with margin pressures, higher input costs, and a sluggish North American volume recovery, compounded by pushback against higher pricing. We anticipate the stock to slide post-earnings as these fundamental drags persist. The main risk to a down call is if the company provided unexpectedly strong forward guidance.

CW

Curtiss-Wright shares dropped 8.00% following a price target reduction from Citi and investor reaction to a CFO transition. Despite solid longer-term aerospace and defense drivers, this executive turnover and analyst downgrade have triggered negative short-term sentiment. We forecast further downside continuation during the session as institutional selling pressure clears. An unexpected defense contract win could introduce upside risk.

MRNA

Moderna climbed almost 5% after Morgan Stanley raised its price target ahead of the upcoming Q3 earnings release. The pre-earnings upgrade signals improving institutional confidence in their commercial execution. We expect this positive momentum to continue attracting capital throughout the target window. Risks include general biotech sector volatility or abrupt profit-taking following the quick gap up.

DAL

Delta Air Lines is officially scheduled to report Q3 results on Friday afternoon, which will highlight travel demand, fuel cost management, and premium revenue trends. Anticipation ahead of the print is expected to drive the stock upward as the market positions for a potentially strong quarter following recent airline pricing stabilization. A downside risk remains if macroeconomic crude oil price shocks deter travel sector buyers.

Other models on the same run

ModelPicksIntraday alpha vs SPYPicks with positive alpha
PerplexityPEP, DAL, STZ, PFE, BMY-0.44%40%
GPT-6APLD, LEVI, DAL, STZ, PEP+0.94%80%
Muse Spark 1.1PEP, TSM, DAL, LEVI, STZ-1.66%20%
Grok 4ARGX, PENG, PEP, DAL, STZ-0.09%40%
Claude Sonnet 5.5DAL, APLD, WOLF, PEP, LEVI+0.42%60%
DeepSeekDAL, HUM, SPCX, UNH, WOLF+3.12%80%

Written up on ForecastNest Insights: Event Gaps: Gemini 1.5 Pro's picks for 2026-10-08.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.